PNC Financial Services Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
PNC Financial Services Group's ANAB Position: Q2 2026 in Review
PNC Financial Services Group reduced its AnaptysBio (ANAB) stake by 4.6% in Q2 2026, selling an estimated $303 and leaving 104 shares worth $7.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4255.
PNC Financial Services Group first reported a position in ANAB in Q1 2018 and has held it in 26 quarters since. The position peaked at $20K in Q2 2018. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- PNC Financial Services Group held 104 shares of AnaptysBio worth $7.02K as of Q2 2026.
- PNC Financial Services Group sold 5 AnaptysBio shares in Q2 2026, an estimated $303.
- AnaptysBio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4255 holding.
- PNC Financial Services Group first reported a position in AnaptysBio in Q1 2018 and has held it in 26 quarters since.
- PNC Financial Services Group's AnaptysBio position peaked at $20K in Q2 2018.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.